Home
| Log in or Sign Up for full access
| Tracked Organizations
| Recent Tracked Activities
Recent Activities
Activities between Nov. 15, 2024, 8 p.m. and Nov. 22, 2024, 8 p.m.
from: Clinical Trial Technology.
Click on a document link to see the original source document.
Click on the name of an organization to see more organization linkages and timelines.
Document Date: Nov. 21, 2024, 1 p.m. / Source: Business Wire
Activity Class: PartnershipActivity
Partnership:
- Altasciences
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 5 more
- Altasciences
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 4 more
- Metsera
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 1 more
- Metsera
/ Industry: Biopharmaceutical And Biotech Industry, Pharma And Healthcare
Document Extract: This work enabled Metsera to recently initiate a randomized 16-week Phase II trial of MET-097i. In addition to clinical conduct, Altasciences supported Metsera with its Proactive Drug Development solution, including nonclinical, bioanalysis, CRO and program management services for several additional therapeutic candidates. Over the past six months, Altasciences has completed nonclinical work for MET-233i, as well as MET-002, an oral GLP-1 receptor agonist peptide, which has proven instrumental in allowing Metsera to begin clinical trials for both programs this year. " Congratulations to Metsera on reaching this significant milestone in the development of MET-097i ," said Ingrid Holmes, Vice President of Global Clinical Operations at Altasciences. " Metsera is a highly valued partner of Altasciences, and we are proud to have contributed to this program aimed at helping individuals struggling with obesity-related illnesses ."
Document Source: https://www.businesswire.com/news/home/20241121694414/en/Altasciences-Supports-Metsera-in-Their-Early-Stage-Clinical-Trials-for-Obesity
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 12:04 p.m. / Source: GlobeNewswire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
Document Extract: Velocity targets Latin America expansion with the appointment of Renata Berardocco as LATAM Managing Director.
Document Source: https://www.globenewswire.com/news-release/2024/11/21/2985096/0/en/Velocity-targets-Latin-America-expansion-with-the-appointment-of-Renata-Berardocco-as-LATAM-Managing-Director.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 12:04 p.m. / Source: GlobeNewswire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
Document Extract: DURHAM, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) - Velocity Clinical Research, the leading fully integrated clinical site organization, announces the appointment of Renata Berardocco as Executive Vice President and Managing Director for the Latin America (LATAM) region.
Document Source: https://www.globenewswire.com/news-release/2024/11/21/2985096/0/en/Velocity-targets-Latin-America-expansion-with-the-appointment-of-Renata-Berardocco-as-LATAM-Managing-Director.html
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 2 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Innovaderm
/ Industry: Biopharmaceutical And Biotech Industry, Clinical Trial Technology
- Innovaderm
/ Industry: Biopharmaceutical And Biotech Industry, Clinical Trial Technology
Document Extract: Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy.
Document Source: https://www.businesswire.com/news/home/20241119155706/en/Innovaderm-Research-Appoints-Ina-Zschocke-as-New-Executive-Vice-President-European-Operations-and-Strategy
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 2 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
/ Region: Europe
Role:
Person:
Organization:
- Innovaderm
/ Industry: Biopharmaceutical And Biotech Industry, Clinical Trial Technology
- Innovaderm
/ Industry: Biopharmaceutical And Biotech Industry, Clinical Trial Technology
Document Extract: Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy.
Document Source: https://www.businesswire.com/news/home/20241119155706/en/Innovaderm-Research-Appoints-Ina-Zschocke-as-New-Executive-Vice-President-European-Operations-and-Strategy
(archive.org page /
archive.org listing)
Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.
Treat sameAsNameOnly relationship as same? Yes
(Turn Off)
Site Stats
| About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License.
Please send an email if you need a non-share-alike license and/or you need API access.